Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- UBS analyst Michael Ward upgraded Reinsurance Group of America, Incorporated (NYSE:RGA) from Neutral to Buy and raised the price target from $236 to $325. Reinsurance Group closed at $265.55 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Elyse Greenspan upgraded Brown & Brown Inc (NYSE:BRO) from Equal-Weight to Overweight and boosted the price target from $68 to $82. Brown & Brown shares closed at $72.90 on Wednesday. See how other analysts view this stock.
- Leerink Partners analyst Mike Kratky upgraded Abbott Laboratories (NYSE:ABT) from Market Perform to Outperform and announced a $124 price target. Abbott closed at $104.48 on Wednesday. See how other analysts view this stock.
- Barclays analyst Benjamin Theurer upgraded Fomento Economico Mexcn SAB de CV ADR (NYSE:FMX) from Equal-Weight to Overweight and announced a $155 price target. Fomento Economico shares closed at $127.74 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Elyse Greenspan upgraded Marsh & McLennan Companies Inc (NYSE:MRSH) from Equal-Weight to Overweight and raised the price target from $197 to $235. Marsh closed at $205.43 on Wednesday. See how other analysts view this stock.
Considering buying ABT stock? Here’s what analysts think:

Photo via Shutterstock
Recent Comments